Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. CyberKnife Systems requires no anesthesia, and treatment sessions are done on an outpatient basis.
| Website: | www.accuray.com |
| Email: | tkehrli@evcgroup.com |
| Main Phone: | +1 408 716-4600 |
| Address: | 1310 Chesapeake Terrace |
| State: | CA |
| City / Town: | Sunnyvale |
| Country: | USA |
| Postal Code: | 94089 |
| Exchange: | NGS |
| CEO: | Joshua H. Levine |
| Employees: | 998 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
Gathering Data... Please wait Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. CyberKnife Systems requires no anesthesia, and treatment sessions are done on an outpatient basis.
| Website: | www.accuray.com |
| Email: | tkehrli@evcgroup.com |
| Main Phone: | +1 408 716-4600 |
| Address: | 1310 Chesapeake Terrace |
| State: | CA |
| City / Town: | Sunnyvale |
| Country: | USA |
| Postal Code: | 94089 |
| Exchange: | NGS |
| CEO: | Joshua H. Levine |
| Employees: | 998 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
| Last Price 3.98 | Change $ 0.18 | Change % 4.74 | Tick N/A |
| Bid 3.86 | Bid Size 1,000.00 | Ask 4.00 | Ask Size 300.00 |
| Open 3.77 | High 3.99 | Low 3.77 | Prev Close 3.80 |
| Last Trade | Volume 849,200 | 52 Wk Hi 5.40 | 52 Wk Low 3.00 |
| Market Cap 350.3 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 88,024,096.00 | EPS (TTM) -0.18 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 3 | 44 |
| Number of Buys | 0 | 13 |
| Number of Sells | 3 | 31 |
| Net Activity | -14257 | 256223 |
| Last 10 Buys | Shares |
|---|---|
| Joshua H. Levine | 1,000 |
| Joshua H. Levine | 1,000 |
| Joshua H. Levine | 1,000 |
| Richard R. Pettingill | 1,000 |
| Dennis L. Winger | 1,000 |
| Joshua H. Levine | 1,000 |
| Kelly Londy | 1,000 |
| Derek A. Bertocci | 1,000 |
| Derek A. Bertocci | 1,000 |
| Theresa L. Dadone | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Alaleh Nouri | 1,000 |
| Kevin Waters | 1,000 |
| Joshua H. Levine | 1,000 |
| Alaleh Nouri | 1,000 |
| Kevin Waters | 1,000 |
| Joshua H. Levine | 1,000 |
| Andrew J. Kirkpatrick | 1,000 |
| Kevin Waters | 1,000 |
| Kelly Londy | 1,000 |
| Alaleh Nouri | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 10 | 10 | 10 | 10 |
| Low Target Price Estimate | 7 | 7 | 7 | 7 |
| Mean Target Price Estimate | 8.67 | 8.67 | 8.67 | 8.67 |
| Standard Deviation | 1.53 | 1.53 | 1.53 | 1.53 |
| Date of Most Recent Estimate | 05/02/18 | 05/02/18 | 05/02/18 | 05/02/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| SC 13G/A | Amendment to the SC 13G filing | 1 | 2018-06-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2018-06-01 |
| SD | Specialized Disclosure Report | 4 | 2018-05-25 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 42 | 2018-05-02 |
| 8-K | Report of unscheduled material events or corporate changes. | 11 | 2018-04-30 |
| S-8 | Securities offered to employees under employee benefit plans | 60 | 2018-04-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-03 |
| CT ORDER | 1 | 2018-03-09 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 |
| Mean Rec. | 2 | 2 | 2 | 2 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
